omega-n-methylarginine has been researched along with Menopause in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Carbonella, M; Colacurci, N; Fornaro, F; Manzella, D; Paolisso, G | 1 |
Funder, JW; Jennings, GL; Komesaroff, PA; Sudhir, K | 1 |
Ford, GA; Majmudar, NG; Robson, SC | 1 |
2 trial(s) available for omega-n-methylarginine and Menopause
Article | Year |
---|---|
Endothelial function and menopause: effects of raloxifene administration.
Topics: Adult; Blood Flow Velocity; Brachial Artery; Cholesterol, LDL; Chromans; Double-Blind Method; E-Selectin; Endothelium, Vascular; Female; Humans; Intercellular Adhesion Molecule-1; Menopause; omega-N-Methylarginine; Placebos; Postmenopause; Premenopause; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Thiobarbituric Acid Reactive Substances; Triglycerides; Vascular Cell Adhesion Molecule-1; Vasodilation | 2003 |
Estrogen enhances basal nitric oxide release in the forearm vasculature in perimenopausal women.
Topics: Acetylcholine; Adult; Blood Pressure; Estradiol; Female; Forearm; Humans; Lipoproteins; Menopause; Nitric Oxide; Nitric Oxide Synthase; Nitroprusside; omega-N-Methylarginine; Vasodilation | 1996 |
1 other study(ies) available for omega-n-methylarginine and Menopause
Article | Year |
---|---|
Effects of the menopause, gender, and estrogen replacement therapy on vascular nitric oxide activity.
Topics: Arteries; Blood Flow Velocity; Brachial Artery; Enzyme Inhibitors; Estrogen Replacement Therapy; Female; Forearm; Humans; Male; Menopause; Middle Aged; Nitric Oxide; Nitric Oxide Synthase; Nitroglycerin; Norepinephrine; omega-N-Methylarginine; Serotonin; Sex Characteristics; Vasoconstriction; Vasodilator Agents | 2000 |